Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.

Three members of the Src family of tyrosine kinases, src, fyn, and yes, are broadly expressed throughout mouse development. Mutations in the c-src and fyn genes were shown previously to lead to restricted nonoverlapping phenotypes only in a subset of cells in which these kinases are expressed. In this work we show that a mutation in the yes gene does not lead to an overt phenotype. Except for brain, the level or distribution of related kinases is not altered in major tissues. To gain further insight into the possibility that these kinases compensate for each other, animals deficient in multiple src-kinases were generated. Whereas most of the src/fyn or src/yes double mutants die perinatally, a substantial proportion of fyn/yes double mutants are viable but undergo degenerative renal changes leading to diffuse segmental glomerulosclerosis. Taken together, these data are consistent with the hypothesis that, at least in some cells, these kinases are able to compensate for the loss of the other related kinases.

[1]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[2]  Andrew P. McMahon,et al.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain , 1990, Cell.

[3]  M. Sudol,et al.  Expression of cellular-yes protein in mammalian tissues. , 1990, Oncogene.

[4]  T. Yoneda,et al.  Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[6]  J. Fargnoli,et al.  Activation of tyrosine kinase p60fyn following T cell antigen receptor cross-linking. , 1992, The Journal of biological chemistry.

[7]  R. Perlmutter,et al.  Defective T cell receptor signaling in mice lacking the thymic isoform of p59 fyn , 1992, Cell.

[8]  R. W. Steele,et al.  T-lymphocyte subsets in nephrotic syndrome. , 1991, Kidney international.

[9]  J. Brugge,et al.  Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets , 1993, Molecular and cellular biology.

[10]  M. Roussel,et al.  Activation of Src family kinases by colony stimulating factor‐1, and their association with its receptor. , 1993, The EMBO journal.

[11]  T. Yagi,et al.  Constitutive activation of Src family kinases in mouse embryos that lack Csk , 1993, Cell.

[12]  J. Bishop,et al.  The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Wakeham,et al.  Profound block in thymocyte development in mice lacking p56lck , 1992, Nature.

[14]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[15]  Philippe Soriano,et al.  Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice , 1993, Cell.

[16]  A. Burkhardt,et al.  Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Brugge,et al.  Neural tissues express high levels of the cellular src gene product pp60c-src , 1983, Molecular and cellular biology.

[18]  P. Stein,et al.  pp59 fyn mutant mice display differential signaling in thymocytes and peripheral T cells , 1992, Cell.

[19]  R. Pepperkok,et al.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[21]  Cook Mp,et al.  Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. , 1989 .

[22]  K. M. Abraham,et al.  Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59 fyn ) , 1991, Cell.

[23]  H. Varmus,et al.  DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA , 1976, Nature.

[24]  J. Brugge,et al.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Fargnoli,et al.  Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Yamamoto,et al.  CSK: a protein-tyrosine kinase involved in regulation of src family kinases. , 1991, The Journal of biological chemistry.

[27]  S. Courtneidge,et al.  Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. , 1992, Oncogene.

[28]  H. Varmus,et al.  Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity. , 1994, Genes & development.

[29]  S. Courtneidge,et al.  Association between the PDGF receptor and members of the src family of tyrosine kinases , 1990, Cell.

[30]  A. Burgess,et al.  Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. , 1993, The Journal of biological chemistry.

[31]  F. Hoffmann,et al.  Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate. , 1993, Genes & development.

[32]  T. Yagi,et al.  Initial events of myelination involve Fyn tyrosine kinase signalling , 1994, Nature.

[33]  T. Yamamoto,et al.  Monoclonal antibodies to the amino-terminal sequence of the c-yes gene product as specific probes of its expression. , 1990, Oncogene.

[34]  A. Koyama,et al.  A glomerular permeability factor produced by human T cell hybridomas. , 1991, Kidney international.

[35]  H. Hanafusa,et al.  Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.